BIO-UV Group (ALTUV) H2 2025 earnings summary

Executive summary

• EBITDA margin remained resilient at 12.3% in 2025, with net profit rising to €0.8 million, reflecting improved operational efficiency and cost control.

• Revenue declined 9% year-over-year to €35.9 million, mainly due to a sharp drop in the Solutions division, partially offset by strong growth in Services & After-Sales.

• Strong cash flow generation enabled continued reduction in financial debt and a strengthened financial structure.

Financial highlights

• Turnover fell to €35.9 million in 2025 from €39.6 million in 2024, a 9% decrease year-over-year.

• Gross margin improved to 53.4% from 51.3% the previous year.

• EBITDA was €4.4 million, down from €5.3 million, but margin remained strong at 12.3%.

• Net profit (group share) reached €0.8 million, up from breakeven in 2024, with a net margin of 2.2%.

• Free cash flow totaled €3.0 million, with cumulative free cash flow of €12.3 million over the last three years.

Outlook and guidance

• Revenue target for 2026 set between €38 million and €42 million, driven by growth in services and a rebound in overseas solutions sales.

• Anticipates continued dynamic growth in Services & After-Sales and recovery in the swimming pool and aquaculture markets.

• Plans to further reduce debt and pursue external growth opportunities.